Leite de Magnésia Phillips, containing the active ingredient Magnesium Hydroxide, is applied across therapeutic domains where additional symptomatic support is needed, primarily serving as both a saline laxative and an antacid. This compound is relevant for easing symptoms related to systemic imbalance and heightened physiological activity, and may be part of symptomatic management in situations where patients experience symptoms that interfere with routine activities.

The common therapeutic uses include managing occasional constipation and relieving the discomfort associated with heartburn, acid indigestion, and general upset stomach.

In these clinical scenarios, the use of Magnesium Hydroxide assists with maintaining functional stability and supports improved comfort during symptomatic periods. It is commonly used when short-term symptomatic assistance is needed. This compound is relevant for easing symptoms related to heightened physiological activity. Quick Fact: Relevant for easing Digestive Discomfort. Overall, the medicine provides support that helps ease the overall symptom burden, and may support patients during episodes of heightened discomfort.

Regulatory References

1. NIH MedlinePlus Drug Information

Who can and cannot use Leite Magnesia Phillips? — Official Regulatory Information

The eligibility for Phillips' Milk of Magnesia is defined by specific health status and age groups, according to official regulatory documentation. Use is approved for Adults and Children 12 years and older for both laxative and antacid purposes.

---

Classification	Restricted Populations
Absolute Contraindication	Severe Renal Failure / kidney insufficiency.
	Intestinal Obstruction disorders or fecal impaction.
	Undiagnosed abdominal pain, nausea, or vomiting.
	Known hypersensitivity to any component.
Conditional Use/Consultation Required	Any degree of kidney disease.
	Patients on a magnesium-restricted diet.
	Patients with a sudden change in bowel habits lasting more than two weeks.

---

Age-Related Eligibility

The preparation is not recommended for use in children under 2 years of age as safety and effectiveness are not established in this group. For children between 2 and 12 years, use is generally restricted, requiring the consultation of a health professional.

Pregnancy and Lactation Status

Official labeling requires individuals who are pregnant or breastfeeding to ask a health professional before use, establishing a mandatory consultation threshold for these populations.

The medicine’s interaction profile is primarily characterized by pharmacokinetic interference resulting in reduced systemic exposure of many co-administered oral drugs. This effect is documented for several medicinal categories, including Tetracycline and Fluoroquinolone Antibiotics, Thyroid Hormones (levothyroxine), Digoxin, and Bisphosphonates. Reduced absorption is also noted for oral Iron Supplements.

Interaction Constraint	Requirement/Restriction
Timing Separation	Other oral medications must be administered at least 2 hours before or after this product. Fluoroquinolone antibiotics require a separation of at least 4 hours.
Pharmacodynamic Effect	Co-administration with Salicylates may result in increased excretion of the salicylate compound due to urine pH modification.
Population-Specific Risk	Use in patients with renal impairment is linked to a heightened risk of Hypermagnesemia (excessive plasma magnesium levels) due to reduced renal clearance of the active ion.

Severe renal failure is classified as a formal restriction for use, and co-administration of certain Integrase Inhibitors is officially restricted. The overall interaction profile is defined by a clinically significant absorption-failure risk, which regulatory documents address through mandatory time-separation protocols to prevent reduced effectiveness of essential concomitant therapies.

Laxative Mechanism

In the intestinal lumen, magnesium hydroxide is poorly absorbed. The presence of the unabsorbed magnesium ions (Mg^2+) increases the osmotic pressure gradient. This osmotic effect draws water from the surrounding intestinal mucosa and vasculature into the bowel lumen. The retained water increases the volume and softens the consistency of the intestinal luminal contents. The increased luminal pressure induces stretch receptors in the colonic wall, stimulating an increase in propulsive motility.

Antacid Mechanism

Furthermore, magnesium hydroxide reacts with hydrochloric acid (HCl) in the stomach to produce magnesium chloride (MgCl2) and water, which neutralizes gastric HCl. This neutralization is achieved through the hydroxide component (OH^-), which accepts protons (H^+), resulting in a decrease in the hydrogen ion concentration in the stomach lumen.

How to Use Leite Magnesia Phillips: Official Administration Guidelines

The administration of the oral suspension, containing the active ingredient Magnesium Hydroxide, is defined by a dual dosing protocol specific to the intended therapeutic role—either as a laxative or as an antacid—as outlined in official regulatory documents. This approach governs the dose volume, frequency, and duration of use.

Administration Scope

Feature	Laxative Use	Antacid Use
Route of Administration	Oral Suspension	Oral Suspension
Dosing Schedule (Adults ge 12 years)	30 mL to 60 mL per dose	5 mL to 15 mL per dose
Frequency Pattern	Once daily or in divided doses	As-needed (up to 4 times per day)
Course Duration	Generally not for more than 7 days	Typically limited to short-term, symptomatic use

---

Procedural Administration Steps

The official protocol requires specific preparation and liquid intake. Before administration, the oral suspension must be shaken well. Doses must be accurately measured prior to intake. When used as a laxative, each dose is officially instructed to be followed by a full glass of liquid to facilitate its action.

Age-Group Administration: The regulatory protocol defines a lower dose range for children aged 6 to 11 years when the product is used as a laxative (15 mL to 30 mL). For children under 6 years for laxative use, or under 12 years for antacid use, official guidance directs consulting a healthcare provider.

Usage Constraint: The established maximum daily dose for the preparation must not be exceeded within a 24-hour period.

Research evidence / Overview of studies for Leite Magnesia Phillips

Evidence for Use as a Saline Laxative: Occasional Constipation

Research has explored the use of Magnesium Hydroxide (the active ingredient in Leite Magnesia Phillips) for the temporary management of infrequent bowel movements. Studies conducted include short-term Randomized Controlled Trials (RCTs) and systematic reviews. These trials focused on functional outcomes related to physical discomfort, such as the frequency of defecation and stool consistency, as measured by patient-reported outcomes.

Evidence suggests that the data show patterns related to temporary changes in bowel function in the observed populations. Some research also compared Magnesium Hydroxide against a placebo or other active comparators. The evidence base for this use is considered by some guideline bodies to be moderate, but data for certain groups remain insufficient, and long-term effects are not fully established.

Evidence for Use as an Antacid: Heartburn and Acid Indigestion

The evidence for the use of Magnesium Hydroxide as an antacid primarily focuses on its established chemical profile and its regulatory classification. Research examined outcomes related to gastric acid neutralization, which is an outcome linked to inflammatory or irritative states. Studies also explored patient-reported outcomes describing perceived discomfort from heartburn and acid indigestion.

Research so far indicates that studies monitored the rate and duration of pH changes within the stomach. Findings describe patterns related to chemical neutralization observed over short time intervals. This evidence contributes to the broader evidence landscape supporting its regulatory classification. The evidence for this indication is largely considered high by regulatory bodies, although data are still emerging regarding its isolated, repeated use over time.

Research into Long-Term Outcomes and Limitations

Research highlights changes measured during the study period, but the available data do not provide individual predictions regarding sustained patterns over many months or years. Long-term effects are not fully established, as existing studies provide limited insight into outcomes beyond the immediate symptom-management period.

Research has explored the use of the medicine in specific study populations, including adults and children, those with opioid-induced constipation, and pregnant individuals experiencing heartburn. However, for groups such as the geriatric population, the follow-up durations were often limited, meaning results related to long-term outcomes for the geriatric population remain uncertain. Comparative evidence is also limited regarding how Magnesium Hydroxide was evaluated against newer osmotic agents for constipation.

Key Studies & References

1. Magnesium Hydroxide - Drug Information (Laxative Use)
2. Magnesium Hydroxide - Drug Information (Antacid Use)
3. Efficacy and safety of treatments for chronic constipation: an updated systematic review and meta-analysis

Common questions about Leite Magnesia Phillips (FAQ)

Q: What is the difference between Leite Magnesia Phillips and other types of laxatives?

A: Official product information describes Leite Magnesia Phillips as a saline osmotic laxative. This means it works by drawing water into the intestine to soften the stool and assist movement. This osmotic action is distinct from stimulant laxatives, which directly prompt contractions of the colon.

Q: Is Leite Magnesia Phillips the same as taking a magnesium supplement?

A: The active ingredient, Magnesium Hydroxide, is chemically recognized for use as a nutrient supplement in other contexts. However, this preparation is regulated and primarily intended as an over-the-counter medicine for the temporary management of constipation and relief of acid indigestion, and it is not typically positioned as a primary source for daily nutritional magnesium supplementation.

Q: Why is the medicine commonly referred to as 'Milk of Magnesia'?

A: The common name 'Milk of Magnesia' is historical, originating as the proprietary name for the original preparation in the late 19th century. This name refers to the product's physical appearance, as it is a milky white liquid suspension of magnesium hydroxide in water.

Q: How fast should I typically expect Leite Magnesia Phillips to start working for constipation?

A: Label information indicates that the onset of action may be observed within a general timeframe of 30 minutes to 6 hours after administration. This timing allows the osmotic effect to facilitate bowel function, though individual results may vary.

Q: What is the difference in how the liquid and tablet versions of the medicine affect the body?

A: Both the liquid suspension and tablet forms contain the same active ingredient, Magnesium Hydroxide, and are generally dosed to achieve the same therapeutic effect, whether for antacid or laxative use. The liquid suspension is the primary and most commonly referenced formulation in official regulatory texts.

Q: Can prolonged use of Leite Magnesia Phillips lead to dehydration?

A: The medicine works using an osmotic effect, meaning it draws water into the colon to function. Excessive or prolonged use can potentially lead to fluid and electrolyte imbalances in the body. Regulatory guidelines emphasize the importance of limiting use to the specified duration.

Q: What signs might indicate a person is experiencing a severe or unusual side effect?

A: The most critical, though rare, severe side effect is Hypermagnesemia (excessive plasma magnesium levels). Signs that may indicate this condition include confusion, unusual drowsiness, facial flushing, muscle weakness, or a slow or irregular heartbeat.

Q: Does using this medicine increase the risk of the body becoming dependent on laxatives?

A: Regulatory information and research generally suggest that as an osmotic laxative, Leite Magnesia Phillips is not associated with the same risk of dependence or 'habit-forming' behavior often linked to stimulant laxatives.

Q: Does Leite Magnesia Phillips interfere with the effectiveness of certain antibiotics or oral contraceptives?

A: Regulatory documents confirm that this medicine interferes with the absorption and effectiveness of certain prescription drugs, notably specific types of antibiotics like Tetracyclines and Fluoroquinolones. Regulatory documents do not include established evidence confirming interference with oral contraceptives.

Q: Is it necessary to separate the time of taking Leite Magnesia Phillips from other vitamins or supplements?

A: Yes, taking this medicine too close to some supplements can interfere with their absorption. Time separation, typically 2 to 4 hours, is required for oral Iron supplements and may also be needed for specific vitamins and other supplements, such as Vitamin D and Alpha-Lipoic Acid.

Q: Should individuals with heart conditions or those on a magnesium-restricted diet avoid the medicine?

A: Official information states that individuals on a magnesium-restricted diet are in a conditional-use category requiring consultation before use. Similarly, individuals with heart conditions that may be sensitive to electrolyte imbalances may need to consult a health professional due to the elevated risk of Hypermagnesemia (magnesium excess).

Q: Is Leite Magnesia Phillips a suitable option for older adults?

A: Caution is officially advised for use in older adults. Reduced kidney function is more common in this population, which increases the risk of accumulating excessive magnesium levels in the body, which could lead to adverse effects.

Q: Why does the liquid form of the medicine sometimes look watery or separate?

A: This preparation is chemically defined as an oral suspension, which is a mixture of fine solid particles suspended in a liquid base. As the solid components naturally settle upon standing, the container must be shaken well before measuring and administering each dose to ensure consistent content.

Q: What is the difference between the regular and concentrated liquid formulations?

A: Concentrated formulations contain a higher amount of the active ingredient, Magnesium Hydroxide, per measured volume of liquid compared to the regular strength. This difference means the concentrated liquid allows for a smaller total dose volume to deliver the same therapeutic effect.

Q: Can the tablet form of Leite Magnesia Phillips be safely cut or crushed?

A: Regulatory instructions for administration typically focus on swallowing the tablet whole. Crushing or cutting oral tablets may alter the intended function or dissolution rate, so the liquid formulation may be preferred for individuals who cannot swallow the tablet whole.

Q: Why do the instructions often suggest taking it before bedtime?

A: Regulatory dosing labels often include taking the medicine before bedtime as a timing option for the laxative indication. This is suggested because the product's expected onset of action (30 minutes to 6 hours) often results in a desired bowel movement the following morning.

Q: Does the medicine expire, and is it safe to use after the expiration date?

A: All drug products are required by regulatory bodies to have an expiration date established through stability testing. Regulatory requirements ensure product quality is maintained only up to the printed expiration date, and use past this date is not recommended.

Q: Does the product contain any known allergens or specific non-medicinal ingredients?

A: Regulatory requirements mandate the listing of all non-medicinal ingredients, including flavors and any major allergens, on the product label. Individuals may reference the specific packaging for this mandated information prior to use.

Q: Why is it advised to drink a full glass of water with each dose of the medicine?

A: Official administration protocol advises following the dose with a full glass of liquid when using the medicine as a laxative. This liquid is required to assist the active ingredient in creating the necessary osmotic effect, which draws water into the bowel lumen to produce a bowel movement.

Q: What should a person do if Leite Magnesia Phillips does not produce a bowel movement within 6 hours?

A: Since the expected maximum onset of action is generally within 6 hours, if no result occurs or if constipation continues for more than the maximum specified duration of 7 days, it may be appropriate to consult a health professional.

Storage and Disposal Requirements

Leite Magnesia Phillips (Magnesium Hydroxide) must be stored at controlled room temperature, typically between 20^circ and 25 C (68^circ to 77 F). The regulatory labeling mandates that the product must not be frozen, as freezing can compromise the liquid suspension's stability and cause separation. The container must be kept tightly closed after each use and must not be stored above 40 C. For safety, it is a mandatory requirement to store the medicine in a secure location and out of the sight and reach of children.

Expired or unused medication must be disposed of safely. Disposal must be strictly carried out in accordance with all applicable local and national laws and regulations for pharmaceutical waste.